Top New York Biochemistry Schools : Programs, Colleges …

Posted on by

Biochemistry Schools in New York

New York contains 50 schools that offer biochemistry programs. Columbia University in the City of New York, the highest-ranking biochemistry school in NY, has a total student population of 24,230 and is the 4th highest ranked school in America.

Of the 50 biochemistry schools in New York, only 10 have a student population over 10k. After taking into account tuition, living expenses, and financial aid, New York University comes out as the most expensive ($34,011/yr), with CUNY College of Staten Island as the lowest recorded at only $6,884/yr.

Biochemistry students from New York schools who go on to become biochemists, bioengineers, biomedical engineers, biologists, etc. have a good chance at finding employment. For example, there are 22,860 people working as biochemists and biophysicists alone in the US, and their average annual salary is $88,550. Also, Microbiologists make on average $71,980 per year and there are about 16,260 of them employed in the US today. In fact, in the New York alone, there are 830 employed microbiologists earning an average yearly salary of $70,760. Biochemists and biophysicists in this state earn $87,400/yr and there are 1,460 employed.

Also, within the biochemistry schools in New York, the average student population is 2,856 and average student-to-faculty ratio is 16 to 1. Aside from biochemistry, there are 10195 total degree (or certificate) programs in the state, with 3,318 people on average applying for a school. Undergraduate tuition costs are normally around $4,933, but can vary widely depending on the type of school.

Program ID: 43934

Levels offered: Certificate, Bachelors, Masters, PhD

Program ID: 116748

Levels offered: Bachelors, Masters, PhD

Program ID: 195060

Levels offered: Bachelors

Program ID: 18687

Levels offered: Bachelors

Program ID: 40359

Levels offered: Bachelors

Program ID: 188730

Levels offered: Masters, PhD

Program ID: 137555

Levels offered: Bachelors, Masters, PhD

Program ID: 207058

Levels offered: Bachelors, Masters, PhD

Program ID: 100552

Levels offered: Bachelors

Program ID: 139369

Levels offered: Bachelors

Program ID: 81203

Levels offered: Bachelors

Program ID: 139145

Levels offered: Bachelors

Program ID: 9529

Levels offered: Bachelors

Program ID: 141754

Levels offered: Bachelors

Program ID: 199795

Levels offered: Bachelors

Program ID: 72706

Levels offered: Bachelors

Program ID: 49414

Levels offered: Bachelors

Program ID: 160136

Levels offered: Bachelors

Program ID: 159548

Levels offered: Bachelors

Program ID: 172213

Levels offered: Bachelors, Masters, PhD

Program ID: 71513

Levels offered: Bachelors

Program ID: 159702

Levels offered: Bachelors

Program ID: 171638

Levels offered: Bachelors

Program ID: 157279

Levels offered: Bachelors

Program ID: 99928

Levels offered: Bachelors

Program ID: 48393

Levels offered: Masters

Program ID: 149807

Levels offered: Bachelors

Program ID: 159635

Levels offered: Bachelors

Program ID: 115381

Levels offered: Bachelors

Program ID: 160339

Levels offered: Bachelors

Program ID: 30239

Levels offered: Bachelors

Program ID: 160254

Levels offered: Bachelors

Program ID: 92164

Levels offered: Bachelors

Program ID: 75433

Levels offered: Bachelors

Program ID: 140681

Levels offered: Bachelors

Program ID: 128636

Levels offered: Bachelors

Program ID: 80460

Levels offered: Bachelors

Program ID: 160428

Levels offered: Bachelors

Program ID: 165656

Levels offered: Bachelors

Program ID: 100002

Levels offered: Bachelors

Program ID: 48212

Levels offered: Masters

Program ID: 133765

Levels offered: Bachelors

Program ID: 41171

Levels offered: Bachelors

Program ID: 87959

Levels offered: Bachelors

Program ID: 48296

Levels offered: Bachelors

Program ID: 95230

Levels offered: Associates, Bachelors

New York Interesting Facts

Read the original here:
Top New York Biochemistry Schools : Programs, Colleges ...

American Society for Biochemistry and Molecular Biology

Posted on by

Grad students and postdocs: Tell us what resources you need and enter to win a $150 Amazon gift card. Take the survey. July 24: Membrane-Anchored Serine Proteases Symposium late breaking deadline. Kinases and Pseudokinases Symposium: Now accepting abstracts for oral programming consideration. JBC Thematic Minireview Series - Metals at the Host-Pathogen Interface

June 9, 2015This seventh Metals in Biology Thematic Series deals with the metal-based interactions of mammalian hosts with pathogens. Both pathogens and host have complex regulatory systems for metal homeostasis. Understanding these provides strategies for fighting pathogens, either by excluding essential metals from the microbes, by delivery of excess metals to cause toxicity, or by complexing metals in microorganisms. Intervention is possible by delivery of complexing reagents or by targeting the microbial regulatory apparatus.

Read all of the articles in this series here

May 15, 2015The study of cytoskeletal polymers has been an active area of research for more than 70 years. Yet, despite decades of pioneering work by some of the brightest scientists in biochemistry, cell biology and physiology, many central questions regarding the polymers themselves are only now starting to be answered. In this thematic series of mini-reviews, these topics are covered by some of the very same scientists who generated these recent insights, thereby providing us with an overview of the State of the Cytoskeleton in 2015.

Read all of the articles in this series here

The Howard Hughes Medical Institute (HHMI) announced 15 scientist-educators who have been named HHMI professors. Each will receive $1 million over five years "to create activities that integrate their research with student learning in ways that enhance students' understanding of science." Forty scientists have been named HHMI professors since the program began in 2002.

View original post here:
American Society for Biochemistry and Molecular Biology

Oxidative Decarboxylation of Pyruvate, Biochemistry (B.Sc. & M.Sc. Biotechnology) GuruKpo – Video

Posted on by


Oxidative Decarboxylation of Pyruvate, Biochemistry (B.Sc. M.Sc. Biotechnology) GuruKpo
Ms. Rajshri Nagar, Biyani Girls college, Jaipur, explains about Oxidative Decarboxylation of Pyruvate. By this process, pyruvate is converted into Acetyl Co-A. It is a link between Glycolysis...

By: Guru Kpo

Excerpt from:
Oxidative Decarboxylation of Pyruvate, Biochemistry (B.Sc. & M.Sc. Biotechnology) GuruKpo - Video

What is Glycolysis, Biochemistry (B.Sc. & M.Sc. Biotechnology) GuruKpo – Video

Posted on by


What is Glycolysis, Biochemistry (B.Sc. M.Sc. Biotechnology) GuruKpo
Ms. Rajshri Nagar, Biyani Girls college, Jaipur, explains about Glycolysis which play important role in respiration. It is the process of conversion of glucose into pyruvate to form energy....

By: Guru Kpo

View original post here:
What is Glycolysis, Biochemistry (B.Sc. & M.Sc. Biotechnology) GuruKpo - Video

www.asell.org

Posted on by

Posted on Feb 08 2013 by Sam Priest, Natalie Williamson

Ion exchange chromatography is a critical analytical technique routinely used for the separation of compounds based on their charge for a wide range of purposes. This experiment provides students with experience executing the technique, and also builds knowledge of the theory behind how the process works by using ion exchange columns to identify products of hydrolysed copper complexes. In so doing students are also exposed to and gain an understanding of the relationships between the strength of reaction conditions and products produced as a consequence. /span>

Initially, students are asked to identify three complex salts from a mixture by charge and colour using an ion exchange column. Once they have developed a level of confidence in the process of identification, students then expose carbanato bisethylenediamine cobalt (III) chloride to varying conditions of hydrolysis; dilute hydrochloric acid, concentrated hydrochloric acid and hot concentrated hydrochloric acid; and are asked to identify the different species produced in each case. Hydrolysis removes the carbonato ligand from the complex, and students can expect to see the two coordination sites replaced by water or chloride ions to give diaquo, aquochloro and/or dichloro bisethylenediamine cobalt (III) chloride as products, the presence of each being dependant on the availability of chloride ions in comparison to water in each of the three reaction conditions. Students are expected to identify which species are present in each case based on characteristic colour and charge, and answer a series of questions concerning identification methods and reasons the products differ in each case.

Read the original:
http://www.asell.org

The Guardian is the latest old-line publisher to reach outside the business for a CEO – Digiday

Posted on by

Publishers are increasingly looking outside of their own immediate publishing spheres for new chief executive hires, in the hopes of bringing in fresh thinking from a related industry.

This week the Guardian announced that neuroscientist and former academic publisher Annette Thomas would be its new CEO. In September U.K. newspaper group Reach appointed as its new chiefJim Mullen, the former boss of gambling firm Ladbrokes Coral.And in AprilRoger Lynch joined Cond Nast from Pandora, the music streaming service provider. And at the start of last year, USA Todays owner Gannett had instructed its headhunting firm to search beyond the newspaper industry for CEO candidates.

The rationale behind for each publishers deliberations is unique, of course, but the changing (and challenging) nature of the publishing industry is a significant factor. Many of the skills required of a modern publishing executive building consumer revenue, managing the sophisticated use of data and driving workplace cultural change are not readily found among the tried-and-true candidates found within internal ranks or at competitors.

Thomas is a case in point. Many media observers seized on her scientific qualifications her Harvard undergraduate degree in biochemistry and biophysics (achieved with honors) and Yale doctorate in cell biology and neuroscience. But her background in academic publishing might be her most important credential.

In 2007, Thomas became chief executive of Macmillan Publishers, a leading science and education publishing group; she oversaw Macmillans merger with Springer Science and Business Media. And after she spent 23 years helming Macmillan, she became CEO of higher education data business Web of Science Group. Thomas has been lauded for her overall strong leadership skills, after leading both Macmillan and Web of Science through mergers and in the latter case, even a public listing. As one former colleague of Thomas said, shes terrific and [Guardian Media Group needs] a new leadership style.

The Guardians critical membership business will rely on Thomas experience with growing the number of subscriptions and managing churn, observers said.

Thomas will bring fresh thinking, but still, how do you persuade consumers to donate in order to drive meaningful subscription revenue? asked independent media analyst Alex DeGroote. The Guardian is at an inflection point. Its had years of fairly fierce cost cutting; breaking even is not the same is growing. What strategy will she bring to the table?

The appointment of Thomas represents a shift in the leadership at Guardian. She succeeds David Pemsel, who ascended to the CEO post in 2015 after working for the Guardian five years and also performing other media roles, including working at a broadcaster (ITV), a production shop (Shine) and an advertising agency (Ogilvy). Pemsel was responsible for steering the Guardian out of the red and into slim profitabilitythrough heavy cost cutting after two decades of financial losses.During Pemsels CEO tenure, the publisher diversified its revenue model so as to rely more on reader-derived revenue than advertising. Industry onlookers had pegged for the top job strong internal candidates like chief customer officer Anna Bateson,who leads the Guardians membership strategy.

An exclusive, inside look at whats actually happening in the video industry, including original reporting, analysis of important stories and interviews with interesting executives and other newsmakers.

Annette Thomas is a strong appointment because of her substantial experience in global publishing, in all things digital, and in M&A, deals and fundraising, said independent media consultant Colin Morrison. Those strengths point toward what I believe is the Guardians future in using partnerships, joint ventures and strategic alliances to become a truly global and 100% digital news media group.

While Jim Mullens CEO appointment at Reach raised some eyebrows, media observers say the former gambling firm boss has brought his knowledge of how to run a digitally sophisticated, consumer-facing marketing business with an understanding of how people behave. Indeed he is not a newcomer to publishing: From 2006 to 2010, Mullen worked at News UK as director of digital strategy.

And with Roger Lynchs arrival last year at Cond Nast after serving as CEO of Pandora as well as an executive for streaming service provider Sling TV, he brought something quite different than conventional magazine publishing experience: expertise in managing large complex organizations, as well as key growth areas like subscriptions and over-the-top video.

Nonetheless, even though Gannett instructed its headhunting firm to consider CEO candidates with digital or e-commerce backgrounds outside the newspaper industry as possible change agents for USA Today, in AugustGannett ended up appointing Paul Bascobert, a former president of media and technology company XO Group.

But in the Guardians case, the hiring of an executive who has worked outside the consumer publishing business represents a careful balancing act a move to grow the organization in new directions all without losing sight of its core values, according to Douglas McCabe, CEO at Enders Analysis. The CEO of the Guardian needs to be someone who is highly sensitive to the culture of the organization, which has a more complex agenda than most commercial news businesses, but without drowning in it, McCabe said. Annettes experience looks a perfect fit, balancing experience managing the complex culture of a comparable set of industry challenges with commercial nous, data analytics and expertise in planning for long-term, structural, industry change.

Continued here:
The Guardian is the latest old-line publisher to reach outside the business for a CEO - Digiday

What is Fermentation, Biochemistry (B.Sc. & M.Sc. Biotechnology) GuruKpo – Video

Posted on by


What is Fermentation, Biochemistry (B.Sc. M.Sc. Biotechnology) GuruKpo
Ms. Rajshri Nagar, Biyani Girls college, Jaipur, explains about Fermentation. It is an anaerobic process where final electron acceptor is organic compound. In this pyruvate converted either...

By: Guru Kpo

Read the original post:
What is Fermentation, Biochemistry (B.Sc. & M.Sc. Biotechnology) GuruKpo - Video

Home | Department of Chemistry and Biochemistry

Posted on by

FACULTY OPENINGS ABOUT OUR DEPARTMENT

The UO Department of Chemistry and Biochemistry offers undergraduate major and minor degrees in chemistry and biochemistry, and graduate degrees at the masters and PhD level.

Our undergraduate program provides training for students planning careers in the chemical and biological sciences and also for those in biology, health related disciplines, earth sciences, secondary education, business, journalism and law. Undergraduate research and other educational activities outside the traditional classroom are essential components of these majors.

Our graduate program recognizes the importance of diversity and breadth in graduate education and continues to respond to the shifts and changes in career opportunities available to our graduates. Research at the University of Oregon is designed to keep student researchers at the forefront of chemical science.

A unique strength of our program is its interdisciplinary approach to research and teaching. Chemical scientists may be interested in the Institute of Molecular Biology, the Institute of Theoretical Science, the Materials Science Institute, the Oregon Center for Optics, and the programs in cell biology and in molecular synthesis, structure, and dynamics.

View original post here:
Home | Department of Chemistry and Biochemistry

University of Medicine and Dentistry of New Jersey …

Posted on by

University of Medicine and Dentistry of New Jersey

Former names

Academic staff

Administrative staff

Other students

The University of Medicine and Dentistry of New Jersey (UMDNJ) was a state-run health sciences institution of New Jersey, United States. It had eight distinct academic units. It formed an academic health sciences centre. It awarded 1,459 degrees in 20102011.

On June 28, 2012 the New Jersey state legislature passed a bill that dissolved the University of Medicine and Dentistry of New Jersey and merged most of its schools, except the School of Osteopathic Medicine, with Rutgers University forming a new Rutgers School of Biomedical and Health Sciences effective July 1, 2013. Members of the Rutgers board of governors estimated that the takeover of UMDNJ could "elevate Rutgers status to among the top 25 most elite research universities in America."[2] The Stratford-based School of Osteopathic Medicine, along with its Graduate School of Biomedical Sciences, became part of Rowan University and was renamed the Rowan University School of Osteopathic Medicine.

The Seton Hall College of Medicine and Dentistry was incorporated on August 6, 1954. The college enrolled its first class in 1956 at the Jersey City Medical Center. This was the forerunner of the New Jersey Medical School, the New Jersey Dental School, and the Graduate School of Biomedical Sciences. In 1965, the college was acquired by the state of New Jersey and renamed the New Jersey College of Medicine and Dentistry (NJCMD). Meanwhile, The Rutgers Medical School opened in 1966 as a two-year basic science institution offering the master of medical science (M.M.S.) degree. The College of Medicine and Dentistry of New Jersey (CMDNJ) was created by legislature in 1970 with the consolidation of the boards of trustees of Rutgers Medical School (now Robert Wood Johnson Medical School) and New Jersey College of Medicine and Dentistry. In 1981, the CMDNJ was renamed to the University of Medicine and Dentistry of New Jersey.[3] It was the largest school of health sciences of its kind in the United States. It was also the leading research university in New Jersey, edging the other major research universities in the state (including Princeton University and Rutgers University) in federal research grant dollars.[4] It did, however, have various academic partnerships with universities and other institutions in New Jersey.

UMDNJ was made up of 8 schools:

UMDNJ also operated The University Hospital in Newark, while Robert Wood Johnson University Hospital in New Brunswick, Hackensack University Medical Center in Hackensack and Cooper University Hospital in Camden were affiliates of UMDNJ. UMDNJ also operated a palliative care facility for people living with AIDS.

UMDNJ had approximately 7,000 students in more than 100 degree and certificate programs; more than 13,000 employees, including nearly 2,500 faculty members; more than 31,000 alumni and more than 200 education and healthcare affiliates throughout New Jersey. The University was dedicated to pursuing excellence in the education of health professionals and scientists, conducting research, delivering healthcare, and serving the community. The National Science Foundation ranked UMDNJ #71 out of 630 universities and colleges in terms of R&D expenditures.[5]

UMDNJ was involved in a series of blunders that include Medicaid over-billings.[6] The criminal complaint filed against the institution charged that health care fraud occurred through alleged double-billing of Medicaid between May 2001 and November 2004 for physician services in outpatient clinics.[7] A deferred prosecution agreement was filed in federal court in Newark, N.J., Dec. 29, 2005 to avoid prosecution.[8]Herbert Jay Stern, a former U.S. Attorney and federal judge in New Jersey, was appointed as a federal monitor to oversee and enforce compliance in accordance with the deferred prosecution agreement that outlines reform and action to help resolve illegal practices and restore financial integrity and professionalism to the institution.[9] In March 2008, UMDNJ announced that its accreditation by the Middle States Commission on Higher Education had been restored, following the termination of the Deferred Prosecution Agreement; Stern had recommended the return of full responsibility for governance of the institution to the UMDNJ Board of Trustees after implementation of a number of systemic reforms by the Board and administration.[10]

In Stratford, New Jersey, at the UMDNJ School of Osteopathic Medicine, Warren Wallace, the prior Senior Associate Dean for Academic and Student Affairs, was terminated amid accusations of unethical behavior. Accusations include inappropriate use of UMDNJ time and resources for political activities, efforts to obtain no-bid contracts for a friend or neighbor, and inappropriate actions in relation to obtaining admission to the School of Osteopathic Medicine for his daughter.[11]

UMDNJ had placed New Jersey Senator Wayne Bryant on a "no-show" job to increase funding for the school, Bryant being the chairman of the Senate Budget and Appropriations Committee and the Legislature's Joint Budget Oversight Committee. Bryant stepped down from this position in February 2007. The case was investigated by former United States Attorney (later New Jersey governor) Christopher Christie.[12] Bryant was found guilty of the charges on November 19, 2008 and received a four-year sentence in federal prison.[13][14] R. Michael Gallagher, former dean of the School of Osteopathic Medicine, was convicted of bribing Bryant and received an 18-month sentence.[15]

Read more from the original source:
University of Medicine and Dentistry of New Jersey ...

Biochemistry | Open Learning Initiative

Posted on by

Overview:

This is an introductory course in biochemistry, designed for both biology and chemical engineering majors.

A consistent theme in this course is the development of a quantitative understanding of the interactions of biological molecules from a structural, thermodynamic, and molecular dynamic point of view. A molecular simulation environment provides the opportunity for you to explore the effect of molecular interactions on the biochemical properties of systems.

This course assumes that students have taken introductory chemistry, including basic thermodynamics, as well as introductory organic chemistry. An introductory biology course is not a prerequisite for the course, but students would benefit from some prior exposure to biology, even at the high school level. Required mathematical skills include simple algebra and differential calculus.

The two main learning goals of the course are:

The course begins with amino acids and transitions into protein structure and thermodynamics. Protein-ligand binding is treated for both non-cooperative and cooperative binding using immunoglobulins and oxygen transport as examples. The enzymatic function of proteins is explored using serine and HIV proteases as examples. Enzyme kinetics is treated using steady-state kinetic analysis. Enzyme inhibition is treated quantitatively, using HIV protease as a key example.

Carbohydrate and lipids are presented in sufficient depth to allow the student to fully understand major aspects of central metabolism. The discussion of metabolism is focused on energy generation, fermentation, and metabolic control.

The course concludes with an extensive section on nucleic acid biochemistry. The focus of this section is to provide the student with sufficient background so that they are literate in the recombinant DNA technologies as they relate to protein production using recombinant methods.

After a treatment of molecular forces and solution properties, the course builds on molecular and energetic descriptions of fundamental monomeric building blocks to develop a comprehensive understanding of the biological function of polymers and molecular assemblies at the molecular and cellular level. In addition to multiple case studies, the course concludes with a capstone exercise that leads students through the steps required to produce recombinant proteins for drug discovery. The major topics in the course are:

Read more from the original source:
Biochemistry | Open Learning Initiative

Home > Molecular Biophysics & Biochemistry | Yale …

Posted on by

Artistic rendering of dengue virus immediately prior to the fusion of the viral lipid membrane (bottom) to the endosomal membrane of the host cell (top). Two dengue virus envelope protein trimers are shown (in surface representation) on either side of a nascent membrane fusion stalk. Completion of membrane fusion requires the alpha-helical stem regions (shown in worm representation) to anneal onto the core of the E trimers. The image is based on crystal structures of dengue virus E protein in the postfusion conformation determined in the Modis Laboratory. Image created by Janet Iwasa and Gal McGill, Digizyme, Inc.

Vinod Nayak, Moshe Dessau, Kaury Kucera, Karen Anthony, Michel Ledizet & Yorgo Modis (2009). Crystal structure of dengue type 1 envelope protein in the postfusion conformation and its implication for receptor binding, membrane fusion and antibody recognition. J. Virol., 83, 4338-44.

Yorgo Modis, Steven Ogata, David Clements & Stephen C. Harrison (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature, 427, 313-319.

Image from the Modis lab.

The rest is here:
Molecular Biophysics & Biochemistry | Yale ...">Home > Molecular Biophysics & Biochemistry | Yale ...